HSPA5 and cholangiocarcinoma: As shown in Figure S2, PI3K inhibitor LY2940012 not only blocked the activity of mTOR but also inhibited the expression of ATF4 and GRP78 without affecting the phosphorylation of eIF2α in human CCA cells.